In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients. The ...

MSD expects to see an additional $200m layered onto its costs this year as a result of President Trump's tariffs, ahead of any pharma-specific levy.

Education for Sustainable Development (ESD) is UNESCO’s response to the urgent challenges facing our planet. Education for Sustainable Development empowers people with the knowledge, skills, values, ...